Nanobiotix (NBTX) Payables: 2019-2025
- Nanobiotix's Payables fell 36.08% to $13.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $74.8 million, marking a year-over-year increase of 9.55%. This contributed to the annual value of $21.4 million for FY2024, which is 8.53% up from last year.
- Nanobiotix's Payables amounted to $13.2 million in Q2 2025, which was down 38.46% from $21.4 million recorded in Q4 2024.
- In the past 5 years, Nanobiotix's Payables ranged from a high of $21.4 million in Q4 2024 and a low of $7.4 million during Q4 2021.
- In the last 3 years, Nanobiotix's Payables had a median value of $19.6 million in 2023 and averaged $18.6 million.
- Its Payables has fluctuated over the past 5 years, first surged by 84.49% in 2023, then crashed by 36.08% in 2025.
- Nanobiotix's Payables (Quarterly) stood at $7.4 million in 2021, then dropped by 7.06% to $9.9 million in 2022, then spiked by 84.49% to $19.6 million in 2023, then grew by 9.11% to $21.4 million in 2024, then plummeted by 36.08% to $13.2 million in 2025.
- Its last three reported values are $13.2 million in Q2 2025, $21.4 million for Q4 2024, and $20.6 million during Q2 2024.
